245 related articles for article (PubMed ID: 15949505)
21. Gray matter pathology in (chronic) MS: modern views on an early observation.
Geurts JJ; Stys PK; Minagar A; Amor S; Zivadinov R
J Neurol Sci; 2009 Jul; 282(1-2):12-20. PubMed ID: 19249061
[TBL] [Abstract][Full Text] [Related]
22. Optic nerve diffusion changes and atrophy jointly predict visual dysfunction after optic neuritis.
Kolbe S; Chapman C; Nguyen T; Bajraszewski C; Johnston L; Kean M; Mitchell P; Paine M; Butzkueven H; Kilpatrick T; Egan G
Neuroimage; 2009 Apr; 45(3):679-86. PubMed ID: 19162205
[TBL] [Abstract][Full Text] [Related]
23. Rate of brain atrophy in benign vs early multiple sclerosis.
Gauthier SA; Berger AM; Liptak Z; Duan Y; Egorova S; Buckle GJ; Glanz BI; Khoury SJ; Bakshi R; Weiner HL; Guttmann CR
Arch Neurol; 2009 Feb; 66(2):234-7. PubMed ID: 19204160
[TBL] [Abstract][Full Text] [Related]
24. [Use of magnetic resonance imaging in the diagnosis and prognosis of multiple sclerosis].
Zivadinov R; Sepcić J
Lijec Vjesn; 2006; 128(9-10):295-308. PubMed ID: 17128669
[TBL] [Abstract][Full Text] [Related]
25. Brain and spinal cord atrophy in multiple sclerosis.
Simon JH
Neuroimaging Clin N Am; 2000 Nov; 10(4):753-70 ,ix. PubMed ID: 11359723
[TBL] [Abstract][Full Text] [Related]
26. Update on multiple sclerosis.
Simon JH
Radiol Clin North Am; 2006 Jan; 44(1):79-100, viii. PubMed ID: 16297683
[TBL] [Abstract][Full Text] [Related]
27. Voxel-wise assessment of progression of regional brain atrophy in relapsing-remitting multiple sclerosis.
Battaglini M; Giorgio A; Stromillo ML; Bartolozzi ML; Guidi L; Federico A; De Stefano N
J Neurol Sci; 2009 Jul; 282(1-2):55-60. PubMed ID: 19286193
[TBL] [Abstract][Full Text] [Related]
28. T1- and T2-based MRI measures of diffuse gray matter and white matter damage in patients with multiple sclerosis.
Neema M; Stankiewicz J; Arora A; Dandamudi VS; Batt CE; Guss ZD; Al-Sabbagh A; Bakshi R
J Neuroimaging; 2007 Apr; 17 Suppl 1():16S-21S. PubMed ID: 17425729
[TBL] [Abstract][Full Text] [Related]
29. Can rate of brain atrophy in multiple sclerosis be explained by clinical and MRI characteristics?
Korteweg T; Rovaris M; Neacsu V; Filippi M; Comi G; Uitdehaag BM; Knol DL; Polman CH; Barkhof F; Vrenken H;
Mult Scler; 2009 Apr; 15(4):465-71. PubMed ID: 19091881
[TBL] [Abstract][Full Text] [Related]
30. A calculation method for semi automatic follow up of multiple sclerosis by magnetic resonance eco planar perfusion imaging.
Placidi G; Sabatini M; Gallucci M; Sotgiu A
Stud Health Technol Inform; 2003; 95():164-9. PubMed ID: 14663981
[TBL] [Abstract][Full Text] [Related]
31. [Contribution of nuclear magnetic resonance imaging in multiple sclerosis].
Ranjeva JP; Audoin B; Pelletier J; Confavreux C
Rev Prat; 2006 Jun; 56(12):1326-35. PubMed ID: 16948221
[TBL] [Abstract][Full Text] [Related]
32. Correlating MR lesions and functional deficits in multiple sclerosis patients. Anatomical atlas registration.
Gardner JC; Yazdani F
Phys Med Rehabil Clin N Am; 1998 Aug; 9(3):569-86, vi. PubMed ID: 9894110
[TBL] [Abstract][Full Text] [Related]
33. Translating pathology in multiple sclerosis: the combination of postmortem imaging, histopathology and clinical findings.
Seewann A; Kooi EJ; Roosendaal SD; Barkhof F; van der Valk P; Geurts JJ
Acta Neurol Scand; 2009 Jun; 119(6):349-55. PubMed ID: 19254283
[TBL] [Abstract][Full Text] [Related]
34. The pathologic substrate of magnetic resonance alterations in multiple sclerosis.
Lassmann H
Neuroimaging Clin N Am; 2008 Nov; 18(4):563-76, ix. PubMed ID: 19068402
[TBL] [Abstract][Full Text] [Related]
35. Relationship of optic nerve and brain conventional and non-conventional MRI measures and retinal nerve fiber layer thickness, as assessed by OCT and GDx: a pilot study.
Frohman EM; Dwyer MG; Frohman T; Cox JL; Salter A; Greenberg BM; Hussein S; Conger A; Calabresi P; Balcer LJ; Zivadinov R
J Neurol Sci; 2009 Jul; 282(1-2):96-105. PubMed ID: 19439327
[TBL] [Abstract][Full Text] [Related]
36. Grey matter pathology in clinically early multiple sclerosis: evidence from magnetic resonance imaging.
Chard D; Miller D
J Neurol Sci; 2009 Jul; 282(1-2):5-11. PubMed ID: 19201002
[TBL] [Abstract][Full Text] [Related]
37. Magnetic resonance imaging in multiple sclerosis.
Napoli SQ; Bakshi R
Rev Neurol Dis; 2005; 2(3):109-16. PubMed ID: 16400309
[TBL] [Abstract][Full Text] [Related]
38. One-dimensional-ratio measures of atrophy progression in multiple sclerosis as evaluated by longitudinal magnetic resonance imaging.
Martola J; Stawiarz L; Fredrikson S; Hillert J; Bergström J; Flodmark O; Aspelin P; Wiberg MK
Acta Radiol; 2009 Oct; 50(8):924-32. PubMed ID: 19639474
[TBL] [Abstract][Full Text] [Related]
39. Diffusely abnormal white matter in chronic multiple sclerosis: imaging and histopathologic analysis.
Seewann A; Vrenken H; van der Valk P; Blezer EL; Knol DL; Castelijns JA; Polman CH; Pouwels PJ; Barkhof F; Geurts JJ
Arch Neurol; 2009 May; 66(5):601-9. PubMed ID: 19433660
[TBL] [Abstract][Full Text] [Related]
40. Cognitive assessment and quantitative magnetic resonance metrics can help to identify benign multiple sclerosis.
Amato MP; Portaccio E; Stromillo ML; Goretti B; Zipoli V; Siracusa G; Battaglini M; Giorgio A; Bartolozzi ML; Guidi L; Sorbi S; Federico A; De Stefano N
Neurology; 2008 Aug; 71(9):632-8. PubMed ID: 18725589
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
